These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A novel antiviral agent which inhibits the endonuclease of influenza viruses. Tomassini JE; Davies ME; Hastings JC; Lingham R; Mojena M; Raghoobar SL; Singh SB; Tkacz JS; Goetz MA Antimicrob Agents Chemother; 1996 May; 40(5):1189-93. PubMed ID: 8723464 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds. Tomassini J; Selnick H; Davies ME; Armstrong ME; Baldwin J; Bourgeois M; Hastings J; Hazuda D; Lewis J; McClements W Antimicrob Agents Chemother; 1994 Dec; 38(12):2827-37. PubMed ID: 7695269 [TBL] [Abstract][Full Text] [Related]
4. Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay. Baughman BM; Jake Slavish P; DuBois RM; Boyd VA; White SW; Webb TR ACS Chem Biol; 2012 Mar; 7(3):526-34. PubMed ID: 22211528 [TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit. Noshi T; Kitano M; Taniguchi K; Yamamoto A; Omoto S; Baba K; Hashimoto T; Ishida K; Kushima Y; Hattori K; Kawai M; Yoshida R; Kobayashi M; Yoshinaga T; Sato A; Okamatsu M; Sakoda Y; Kida H; Shishido T; Naito A Antiviral Res; 2018 Dec; 160():109-117. PubMed ID: 30316915 [TBL] [Abstract][Full Text] [Related]
6. Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models. Fukao K; Ando Y; Noshi T; Kitano M; Noda T; Kawai M; Yoshida R; Sato A; Shishido T; Naito A PLoS One; 2019; 14(5):e0217307. PubMed ID: 31107922 [TBL] [Abstract][Full Text] [Related]
7. Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance. Nannetti G; Massari S; Mercorelli B; Bertagnin C; Desantis J; Palù G; Tabarrini O; Loregian A Antiviral Res; 2019 May; 165():55-64. PubMed ID: 30885750 [TBL] [Abstract][Full Text] [Related]
8. Polyunsaturated fatty acids from Phyllocaulis boraceiensis mucus block the replication of influenza virus. de Toledo-Piza AR; de Oliveira MI; Negri G; Mendonça RZ; Figueiredo CA Arch Microbiol; 2018 Aug; 200(6):961-970. PubMed ID: 29616305 [TBL] [Abstract][Full Text] [Related]
9. Identification of a novel multiple kinase inhibitor with potent antiviral activity against influenza virus by reducing viral polymerase activity. Sasaki Y; Kakisaka M; Chutiwitoonchai N; Tajima S; Hikono H; Saito T; Aida Y Biochem Biophys Res Commun; 2014 Jul; 450(1):49-54. PubMed ID: 24858693 [TBL] [Abstract][Full Text] [Related]
10. Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors. Jones JC; Kumar G; Barman S; Najera I; White SW; Webby RJ; Govorkova EA mBio; 2018 Apr; 9(2):. PubMed ID: 29691337 [TBL] [Abstract][Full Text] [Related]
11. Characterization and mechanisms of anti-influenza virus metabolites isolated from the Vietnamese medicinal plant Polygonum chinense. Tran TT; Kim M; Jang Y; Lee HW; Nguyen HT; Nguyen TN; Park HW; Le Dang Q; Kim JC BMC Complement Altern Med; 2017 Mar; 17(1):162. PubMed ID: 28327126 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of natural flutimide and analogous fully substituted pyrazine-2,6-diones, endonuclease inhibitors of influenza virus. Singh SB; Tomassini JE J Org Chem; 2001 Aug; 66(16):5504-16. PubMed ID: 11485475 [TBL] [Abstract][Full Text] [Related]